• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解结核分枝杆菌中假定的耐药突变的分子后果。

Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis.

机构信息

Department of Biochemistry and Molecular Biology, Bio21 Institute, University of Melbourne, Victoria, 3051, Australia.

Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

出版信息

Sci Rep. 2018 Oct 18;8(1):15356. doi: 10.1038/s41598-018-33370-6.

DOI:10.1038/s41598-018-33370-6
PMID:30337649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6193939/
Abstract

Genomic studies of Mycobacterium tuberculosis bacteria have revealed loci associated with resistance to anti-tuberculosis drugs. However, the molecular consequences of polymorphism within these candidate loci remain poorly understood. To address this, we have used computational tools to quantify the effects of point mutations conferring resistance to three major anti-tuberculosis drugs, isoniazid (n = 189), rifampicin (n = 201) and D-cycloserine (n = 48), within their primary targets, katG, rpoB, and alr. Notably, mild biophysical effects brought about by high incidence mutations were considered more tolerable, while different structural effects brought about by haplotype combinations reflected differences in their functional importance. Additionally, highly destabilising mutations such as alr Y388, highlighted a functional importance of the wildtype residue. Our qualitative analysis enabled us to relate resistance mutations onto a theoretical landscape linking enthalpic changes with phenotype. Such insights will aid the development of new resistance-resistant drugs and, via an integration into predictive tools, in pathogen surveillance.

摘要

结核分枝杆菌的基因组研究揭示了与抗结核药物耐药性相关的基因座。然而,这些候选基因座内多态性的分子后果仍知之甚少。为了解决这个问题,我们使用计算工具来量化导致三种主要抗结核药物(异烟肼(n=189)、利福平(n=201)和 D-环丝氨酸(n=48))耐药的点突变在其主要靶点 katG、rpoB 和 alr 内的影响。值得注意的是,高发生率突变引起的温和生物物理效应被认为更耐受,而由单倍型组合引起的不同结构效应反映了它们功能重要性的差异。此外,高度不稳定的突变,如 alr Y388,突出了野生型残基的功能重要性。我们的定性分析使我们能够将耐药性突变与连接焓变与表型的理论景观联系起来。这些见解将有助于开发新的耐药性药物,并通过整合到预测工具中,用于病原体监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/51a855e8281d/41598_2018_33370_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/d75a97e50c73/41598_2018_33370_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/8f79521a5f48/41598_2018_33370_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/de40da9ea8ba/41598_2018_33370_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/739d13746576/41598_2018_33370_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/51a855e8281d/41598_2018_33370_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/d75a97e50c73/41598_2018_33370_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/8f79521a5f48/41598_2018_33370_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/de40da9ea8ba/41598_2018_33370_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/739d13746576/41598_2018_33370_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db5c/6193939/51a855e8281d/41598_2018_33370_Fig5_HTML.jpg

相似文献

1
Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis.理解结核分枝杆菌中假定的耐药突变的分子后果。
Sci Rep. 2018 Oct 18;8(1):15356. doi: 10.1038/s41598-018-33370-6.
2
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.乌干达结核分枝杆菌分离株中利福平及异烟肼耐药相关突变的流行情况和模式。
PLoS One. 2018 May 30;13(5):e0198091. doi: 10.1371/journal.pone.0198091. eCollection 2018.
3
Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.使用基因分型诊断方法无法检测到耐多药结核分枝杆菌的rpoB和katG基因中的突变。
Pan Afr Med J. 2017 Jun 28;27:145. doi: 10.11604/pamj.2017.27.145.10883. eCollection 2017.
4
Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.叙利亚结核分枝杆菌利福平及异烟肼耐药相关突变的特征分析。
Pol J Microbiol. 2012;61(1):23-32.
5
Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.缅甸仰光结核分枝杆菌分离株中异烟肼和利福平耐药相关突变:对快速分子检测的意义
J Antimicrob Chemother. 2009 Oct;64(4):694-701. doi: 10.1093/jac/dkp292. Epub 2009 Aug 26.
6
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial.通过DNA测序对利福平及异烟肼耐药结核分枝杆菌菌株进行基因分型检测:一项随机试验
Ann Clin Microbiol Antimicrob. 2009 Jan 30;8:4. doi: 10.1186/1476-0711-8-4.
7
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.在吉尔吉斯斯坦的耐利福平及异烟肼结核分枝杆菌中 rpoB、katG、inhA 和 ahp 基因突变。
BMC Microbiol. 2018 Mar 22;18(1):22. doi: 10.1186/s12866-018-1168-x.
8
Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam.越南结核分枝杆菌中的多药耐药性和补偿性突变
Trop Med Int Health. 2025 May;30(5):426-436. doi: 10.1111/tmi.14104. Epub 2025 Mar 13.
9
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.在一个耐药结核病发病率较低的国家,表型上对利福平敏感的结核分枝杆菌分离株中出现有争议的 rpoB 突变。
BMC Infect Dis. 2019 Jan 3;19(1):3. doi: 10.1186/s12879-018-3638-z.
10
Differences in rpoB, katG and inhA mutations between new and previously treated tuberculosis cases using the GenoType MTBDRplus assay.采用 GenoType MTBDRplus 检测方法比较新发病例和复治病例中 rpoB、katG 和 inhA 基因突变的差异。
Infect Genet Evol. 2018 Apr;59:48-50. doi: 10.1016/j.meegid.2018.01.022. Epub 2018 Feb 4.

引用本文的文献

1
Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan.台湾耐药结核病病例中的环丝氨酸耐药情况。
Microbiol Spectr. 2025 Jul;13(7):e0342224. doi: 10.1128/spectrum.03422-24. Epub 2025 Jun 9.
2
Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance.大规模统计分析结核分枝杆菌基因组序列,鉴定与多药耐药相关的补偿性突变。
Sci Rep. 2024 May 29;14(1):12312. doi: 10.1038/s41598-024-62946-8.
3
Lineage Distribution Using Whole-Genome Sequencing and Bedaquiline, Clofazimine, and Linezolid Phenotypic Profiles among Rifampicin-Resistant Isolates from West Java, Indonesia.

本文引用的文献

1
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis.全基因组分析多药和广泛耐药结核分枝杆菌。
Nat Genet. 2018 Feb;50(2):307-316. doi: 10.1038/s41588-017-0029-0. Epub 2018 Jan 22.
2
Diversity and evolution of drug resistance mechanisms in .……中耐药机制的多样性与进化 (原文不完整,此为根据现有内容尽量准确的翻译)
Infect Drug Resist. 2017 Oct 13;10:333-342. doi: 10.2147/IDR.S144446. eCollection 2017.
3
SDM: a server for predicting effects of mutations on protein stability.SDM:一种用于预测突变对蛋白质稳定性影响的服务器。
利用全基因组测序以及贝达喹啉、氯法齐明和利奈唑胺表型特征对印度尼西亚西爪哇耐利福平分离株进行谱系分布研究。
Int J Microbiol. 2024 Mar 4;2024:2037961. doi: 10.1155/2024/2037961. eCollection 2024.
4
Exploring the effects of missense mutations on protein thermodynamics through structure-based approaches: findings from the CAGI6 challenges.通过基于结构的方法探索错义突变对蛋白质热力学的影响:来自CAGI6挑战赛的发现
Hum Genet. 2025 Mar;144(2-3):327-335. doi: 10.1007/s00439-023-02623-4. Epub 2024 Jan 16.
5
Rendering protein mutation movies with MutAmore.使用 MutAmore 生成蛋白质突变电影。
BMC Bioinformatics. 2023 Dec 12;24(1):469. doi: 10.1186/s12859-023-05610-8.
6
Characterization on the oncogenic effect of the missense mutations of p53 via machine learning.基于机器学习的 p53 错义突变致癌效应的特征分析。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad428.
7
Uncovering the Molecular Drivers of NHEJ DNA Repair-Implicated Missense Variants and Their Functional Consequences.揭示 NHEJ DNA 修复相关错义变异及其功能后果的分子驱动因素。
Genes (Basel). 2023 Sep 29;14(10):1890. doi: 10.3390/genes14101890.
8
Characterizing and predicting ccRCC-causing missense mutations in Von Hippel-Lindau disease.鉴定和预测 Von Hippel-Lindau 病中导致肾透明细胞癌的错义突变。
Hum Mol Genet. 2024 Jan 20;33(3):224-232. doi: 10.1093/hmg/ddad181.
9
Identifying Innate Resistance Hotspots for SARS-CoV-2 Antivirals Using In Silico Protein Techniques.利用计算机蛋白质技术鉴定 SARS-CoV-2 抗病毒药物的先天耐药热点。
Genes (Basel). 2023 Aug 26;14(9):1699. doi: 10.3390/genes14091699.
10
AI-Driven Enhancements in Drug Screening and Optimization.人工智能驱动的药物筛选和优化增强。
Methods Mol Biol. 2024;2714:269-294. doi: 10.1007/978-1-0716-3441-7_15.
Nucleic Acids Res. 2017 Jul 3;45(W1):W229-W235. doi: 10.1093/nar/gkx439.
4
Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance.基因组、结构生物学与药物发现:应对遗传疾病中的突变及抗生素耐药性的影响
Biochem Soc Trans. 2017 Apr 15;45(2):303-311. doi: 10.1042/BST20160422.
5
Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.结核分枝杆菌转录及转录抑制的结构基础
Mol Cell. 2017 Apr 20;66(2):169-179.e8. doi: 10.1016/j.molcel.2017.03.001. Epub 2017 Apr 6.
6
mCSM-NA: predicting the effects of mutations on protein-nucleic acids interactions.mCSM-NA:预测突变对蛋白质-核酸相互作用的影响。
Nucleic Acids Res. 2017 Jul 3;45(W1):W241-W246. doi: 10.1093/nar/gkx236.
7
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.耐多药、广泛耐药和不可治愈结核病的流行病学、发病机制、传播、诊断及管理
Lancet Respir Med. 2017 Mar 15. doi: 10.1016/S2213-2600(17)30079-6.
8
Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures.琶音:一个用于计算和可视化蛋白质结构中原子间相互作用的网络服务器。
J Mol Biol. 2017 Feb 3;429(3):365-371. doi: 10.1016/j.jmb.2016.12.004. Epub 2016 Dec 10.
9
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.肌苷单磷酸脱氢酶GuaB2是一种针对结核病的新型易损杀菌药物靶点。
ACS Infect Dis. 2017 Jan 13;3(1):5-17. doi: 10.1021/acsinfecdis.6b00102. Epub 2016 Sep 8.
10
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis.必不可少但不易受影响:以肌苷单磷酸脱氢酶为靶点的吲唑磺酰胺作为抗结核分枝杆菌的潜在先导化合物
ACS Infect Dis. 2017 Jan 13;3(1):18-33. doi: 10.1021/acsinfecdis.6b00103. Epub 2016 Oct 17.